Nissan Medical Industries Ltd (TLV:NISA)
940.00
-19.90 (-2.07%)
Sep 10, 2026, 1:36 PM IDT
Nissan Medical Industries Revenue
Nissan Medical Industries had revenue of 133.56M ILS in the quarter ending June 30, 2026, a decrease of -19.63%. This brings the company's revenue in the last twelve months to 607.36M, down -3.28% year-over-year. In the year 2025, Nissan Medical Industries had annual revenue of 651.78M, down -1.85%.
Revenue (ttm)
607.36M
Revenue Growth
-3.28%
P/S Ratio
0.14
Revenue / Employee
1.61M
Employees
378
Market Cap
85.39M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 651.78M | -12.30M | -1.85% |
| Dec 31, 2024 | 664.08M | -69.84M | -9.52% |
| Dec 31, 2023 | 733.91M | 49.27M | 7.20% |
| Dec 31, 2022 | 684.65M | 16.28M | 2.44% |
| Dec 31, 2021 | 668.37M | -53.11M | -7.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 51.58B |
| Danel (Adir Yeoshua) | 2.98B |
| Amal Holdings A.D. | 2.18B |
| Rekah Pharmaceutical Industry | 304.04M |
| BrainsWay | 180.82M |
| Seach Medical Group | 154.32M |
| Golden House | 46.05M |
| Almeda Ventures Limited Partnership | 31.99M |